Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)Income from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeTax ProvisionsTax RateTax Rate
Others
Ratios

DiaMedica Therapeutics (DMAC) Shares Outstanding (Weighted Average) (2018 - 2019)

DiaMedica Therapeutics' Shares Outstanding (Weighted Average) history spans 2 years, with the latest figure at $12.0 million for Q3 2019.

  • For Q3 2019, Shares Outstanding (Weighted Average) rose 61.77% year-over-year to $12.0 million; the TTM value through Sep 2019 reached $12.0 million, up 61.77%, while the annual FY2018 figure was $7.7 million, N/A changed from the prior year.
  • Shares Outstanding (Weighted Average) reached $12.0 million in Q3 2019 per DMAC's latest filing, roughly flat from $12.0 million in the prior quarter.
  • In the past five years, Shares Outstanding (Weighted Average) ranged from a high of $12.0 million in Q3 2019 to a low of $6.5 million in Q1 2018.